loading...| Preferred Name |
obeticholic acid |
|
| Synonyms |
DSP-1747 |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C464660 |
|
| altLabel |
DSP-1747 6-ECDCA 6alpha-ethyl-3alpha,7alpha-dihydroxy-5beta-cholan-24-oic acid 6-ethyl-3,7-dihydroxycholan-24-oic acid 6ECDCA 6-ethyl chenodeoxycholic acid cholan-24-oic acid, 6-ethyl-3,7-dihydroxy-, (3alpha,5beta,6alpha,7alpha)- 6alpha-ethyl-chenodeoxycholic acid 6-ethylchenodeoxycholic acid INT747 INT 747 Ocaliva INT-747 DSP1747 |
|
| cui |
C2830015 C4271005 C1143018 C4307728 |
|
| Has mapping qualifier | ||
| HM |
D002635/Q000031 |
|
| Inverse of RB |
0462Z4S4OZ |
|
| LT |
TRD |
|
| Mapped to | ||
| MDA |
20020831 |
|
| MeSH Frequency |
323 |
|
| MMR |
20161006 |
|
| notation |
C464660 |
|
| prefLabel |
obeticholic acid |
|
| SC |
1 |
|
| Scope Statement |
A farnesoid X receptor agonist and anticholestatic agent that is used in the treatment of chronic liver diseases; structure in first source. |
|
| SRC |
J Med Chem 2002 Aug 15;45(17):3569-72 |
|
| TERMUI |
T000908616 T518066 T816534 T000908862 T518064 T816535 T816532 T518065 T000870768 T000870767 T816533 T000908619 T000870799 T000908617 T816531 |
|
| TH |
NLM (2002) FDA SRS (2017) NLM (2012) USAN (19XX) INN (19XX) NLM (2017) NLM (2014) |
|
| tui |
T109 T121 |